2000
DOI: 10.4067/s0034-98872000001100013
|View full text |Cite
|
Sign up to set email alerts
|

Gen supresor de tumores p53 en neoplasias digestivas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…Current evidence indicates that alterations of P53 at the gene level occur late in the pathogenesis of cancer and that the most frequent mechanism of inactivation corresponds to mutation of one allele followed by the deletion of the remaining allele (Gallego et al, 2010). As a result, TP53 gene alterations are useful signals of many types of cancer in humans (Roa et al, 2002). Likewise, in a recent study using exome sequencing in twelve types of cancer, P53 was the most frequently mutated gene in most cancer types studied (Duffy et al, 2017).…”
Section: P53 Variations Databases: Uniprotmentioning
confidence: 97%
“…Current evidence indicates that alterations of P53 at the gene level occur late in the pathogenesis of cancer and that the most frequent mechanism of inactivation corresponds to mutation of one allele followed by the deletion of the remaining allele (Gallego et al, 2010). As a result, TP53 gene alterations are useful signals of many types of cancer in humans (Roa et al, 2002). Likewise, in a recent study using exome sequencing in twelve types of cancer, P53 was the most frequently mutated gene in most cancer types studied (Duffy et al, 2017).…”
Section: P53 Variations Databases: Uniprotmentioning
confidence: 97%
“…Current evidence indicates that alterations of P53 at the gene level occur late in the pathogenesis of cancer and that the most frequent mechanism of inactivation corresponds to mutation of one allele followed by the deletion of the remaining allele (Gallego et al, 2010). As a result, TP53 gene alterations are useful signals of many types of cancer in humans (Roa et al, 2002). Likewise, in a recent study using exome sequencing in twelve types of cancer, P53 was the most frequently mutated gene in most cancer types studied (Duffy et al, 2017 Lim et al, 2010;Casson et al, 1991;Sjoeblom et al, 2006;Das et al, 2007;Frebourg et al, 1995;Varley et al, 1995 193-193 H → R In LFS; Germinal mutation and in sporadic cancer; somatic mutation.…”
Section: P53 Variations Databases: Uniprotmentioning
confidence: 98%
“…Cancer is the result of the accumulation of multiple alterations in the genes that regulate cell growth and are considered critical for the progressive transformation of non-cancerous cells to malignant cells (Sánchez, 2006;Pierce, 2009;Herrera et al, 2010;Risueño, 2012). Some alterations include point mutations, chromosome disruption, repair interruption, epigenetic alterations, and oncogene rearrangements as well as loss or alteration in the function of tumor suppressor genes (Roa et al, 2000;Pierce, 2009). Among the tumor suppressor genes most commonly altered in various cancers, the tumor suppressor gene TP53 is notable.…”
Section: T P 5 3 I N T H E D E V E L O P M E N T O F C a N C E Rmentioning
confidence: 99%
See 1 more Smart Citation